90804919
Jun 30, 2021
House mark for pharmaceutical and therapeutic preparations for the treatment of patients with viral diseases, fungal diseases, and chronic diseases, namely, cancer, kidney disease, diabetes, cachexia, age related sarcopenia, and protein-energy wasting, none of the foregoing to be used for pharmaceutical preparations for treatment of rheumatoid arthritis and psoriasis
Pharmaceuticals